Thrombelastography in Horses with Acute Gastrointestinal Disease

Journal of Veterinary Internal Medicine

Volumn 25, Issue 2, 2011, Pages 307-314

  Epstein, K L ^a   Brainard, B M ^a   Gomez Ibanez, S E ^b,c   Lopes, M A F ^c   Barton, M H ^a   Moore, J N ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b Essex Equine Inc   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Coagulopathy; Point of care coagulation testing; Viscoelastic coagulation testing

Indexed keywords

BLOOD CLOTTING FACTOR; THROMBOPLASTIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GASTROINTESTINAL DISEASE; HEMOSTASIS; HORSE; HORSE DISEASE; MALE; METABOLISM; METHODOLOGY; MORTALITY; PHYSIOLOGY; PROSPECTIVE STUDY; SURVIVAL; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL DISEASES; HEMOSTASIS; HORSE DISEASES; HORSES; MALE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBELASTOGRAPHY; THROMBOPLASTIN;

ANIMALIA; EQUIDAE;

EID: 79952337995     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0673.x     Document Type: Article

References (36)

1. Dallap Schaer BL, Epstein K. Coagulopathy of the critically ill equine patient. J Vet Emerg Crit Care 2009;19:53-65.
2. Topper MJ, Prasse KW. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic. Am J Vet Res 1996;57:456-462.
3. Darien BJ, Potempa J, Moore JN, et al. Antithrombin III activity in horses with colic: An analysis of 46 cases. Equine Vet J 1991;23:211-214.
4. Johnstone IB, Crane S. Haemostatic abnormalities in horses with colic-Their prognostic value. Equine Vet J 1986;18:271-274.
5. Dolente BA, Wilkins PA, Boston RC. Clinicopathologic evidence of disseminated intravascular coagulation in horses with acute colitis. J Am Vet Med Assoc 2002;220:1034-1038.
6. Dallap BL, Dolente B, Boston R. Coagulation profiles in 27 horses with large colon volvulus. J Vet Emerg Crit Care 2003;13:215-225.
7. Welles EG, Prasse KW, Moore JN. Use of newly developed assays for protein C and plasminogen in horses with signs of colic. Am J Vet Res 1991;52:345-351.
8. Collatos C, Barton MH, Prasse KW, et al. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. J Am Vet Med Assoc 1995;207:465-470.
9. Collatos C, Barton MH, Moore JN. Fibrinolytic activity in plasma from horses with gastrointestinal diseases: Changes associated with diagnosis, surgery, and outcome. J Vet Intern Med 1995;9:18-23.
10. Collatos C, Barton MH, Schleef R, et al. Regulation of equine fibrinolysis in blood and peritoneal fluid based on a study of colic cases and induced endotoxaemia. Equine Vet J 1994;26:474-481.
11. Henry MM, Moore JN. Whole blood re-calcification time in equine colic. Equine Vet J 1991;23:303-308.
12. Johnstone IB, Crane S. Hemostatic abnormalities in equine colic. Am J Vet Res 1986;47:356-358.
13. Henry MM, Moore JN. Clinical relevance of monocyte procoagulant activity in horses with colic. J Am Vet Med Assoc 1991;198:843-848.
14. Welch RD, Watkins JP, Taylor TS, et al. Disseminated intravascular coagulation associated with colic in 23 horses (1984-1989). J Vet Intern Med 1992;6:29-35.
15. Prasse KW, Topper MJ, Moore JN, et al. Analysis of hemostasis in horses with colic. J Am Vet Med Assoc 1993;203:685-693.
16. Topper MJ, Prasse KW. Analysis of coagulation proteins as acute-phase reactants in horses with colic. Am J Vet Res 1998;59:542-545.
17. Monreal L, Angles A, Espada Y, et al. Hypercoagulation and hypofibrinolysis in horses with colic and DIC. Equine Vet J 2000;Suppl 32:19-25.
18. Feige K, Kastner SB, Dempfle CE, et al. Changes in coagulation and markers of fibrinolysis in horses undergoing colic surgery. J Vet Med A Physiol Pathol Clin Med 2003;50:30-36.
19. Cesarini C, Monreal L, Armengou L, et al. Association of admission plasma d-dimer concentration with diagnosis and outcome in horses with colic. J Vet Intern Med 2010;24:1490-1497.
20. Donahue SM, Otto CM. Thromboelastography: A tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005;15:9-16.
21. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care 2009;19:484-488.
22. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000;217:1500-1504.
23. Johansson PI, Stensballe J, Vindelov N, et al. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 21:168-174.
24. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009;67:266-275; discussion 275-266.
25. Epstein KL, Brainard BM, Lopes MA, et al. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care 2009;19:96-101.
26. Leclere M, Lavoie JP, Dunn M, et al. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses. Vet Clin Pathol 2009;38:462-466.
27. Mendez-Angulo JL, Mudge MC, Vilar-Saavedra P, et al. Thrombelastography in healthy horses and horses with inflammatory gastrointestinal disorders and suspected coagulopathies. J Vet Emerg Crit Care 2010;20:488-493.
28. Hinchcliff KW, Kociba GJ, Mitten LA. Diagnosis of EDTA-dependent pseudothrombocytopenia in a horse. J Am Vet Med Assoc 1993;203:1715-1716.
29. Corley KT, Donaldson LL, Furr MO. Arterial lactate concentration, hospital survival, sepsis and SIRS in critically ill neonatal foals. Equine Vet J 2005;37:53-59.
30. Roussel AJ Jr, Cohen ND, Hooper RN, et al. Risk factors associated with development of postoperative ileus in horses. J Am Vet Med Assoc 2001;219:72-78.
31. Mavrommatis AC, Theodoridis T, Economou M, et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: Comparison with severe sepsis and septic shock. Intensive Care Med 2001;27:1853-1859.
32. Nesheim M. Thrombin and fibrinolysis. Chest 2003;124:33S-39S.
33. Johnstone IB. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro. Can J Comp Med 1983;47:172-179.
34. Meyers KM, Lindner C, Katz J, et al. Phenylbutazone inhibition of equine platelet function. Am J Vet Res 1979;40:265-270.
35. Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007;68:251-257.
36. Ganter MT, Hofer CK. Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106:1366-1375.